Rebaz M. Ali, et al. “Pembrolizumab (Anti-PD-1) Immunotherapy in Malignant Pleural Mesothelioma: A Systematic Review of the Current Literature”. Barw Medical Journal, July 2023, https://doi.org/10.58742/bmj.v1i2.34.